All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.
Market Valuation Set to Surge from USD 13.23 Billion in 2024 at a CAGR of 5.69% ...
BioMarin’s Voxzogo has been shown to increase growth rates in children with hypochondroplasia, a genetic cause of very short stature, in a phase 2 trial. Hypochondroplasia is a form of skeletal ...
© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...
About argenx SE and BioMarin Pharmaceutical Inc. argenx SE, a biotechnology company, engages in the developing of various therapies for the treatment of autoimmune diseases in the United States, Japan ...
BioMarin Pharmaceutical (Nasdaq: BMRN) reported $747.31 million in revenue for the fourth quarter, a 16% year-over-year increase. The San Rafael-based global producer of genetic treatments for ...
March is considered one of the best months to visit Japan, thanks to its mild weather, colorful blooms, and vibrant cultural events. As winter wanes, plum and early cherry blossoms emerge in warmer ...
Want to relive that Japanese holiday, or get your eye in before you head overseas? You're in luck, because Melbourne is full of top-tier Japanese restaurants. Whether you’re craving sushi, ramen, ...
Currently, patients are commonly treated with Biomarin Pharmaceuticals’ Kuvan (sapropterin dihydrochloride), an enzyme cofactor therapy, or Palynziq (pegvaliase), an enzyme replacement therapy. Next ...
BioMarin's enzyme replacement therapy (ERT) business, particularly Naglazyme and Palynziq, has shown strong growth. The enzyme business grew by 12% year-over-year in 2024, with Palynziq growing by 17% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results